Millennium Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,700
| Closed | -$3.92M | – | 6504 |
|
|
2025
Q1 | $3.92M | Buy |
+29,700
| New | +$3.7M | ﹤0.01% | 3102 |
|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$1.08M | – | 6810 |
|
|
2023
Q1 | $1.08M | Buy |
+20,000
| New | +$967K | ﹤0.01% | 4015 |
|
|
2022
Q4 | – | Sell |
-20,400
| Closed | -$949K | – | 7164 |
|
|
2022
Q3 | $949K | Sell |
20,400
-29,600
| -59% | -$1.55M | ﹤0.01% | 4386 |
|
|
2022
Q2 | $2.85M | Buy |
+50,000
| New | +$2.83M | ﹤0.01% | 3356 |
|
|
2022
Q1 | – | Sell |
-37,500
| Closed | -$1.96M | – | 7622 |
|
|
2021
Q4 | $1.96M | Buy |
+37,500
| New | +$1.58M | ﹤0.01% | 3801 |
|
|
2020
Q4 | – | Sell |
-50,000
| Closed | -$1.28K | – | 5665 |
|
|
2020
Q3 | $1.28K | Buy |
50,000
+25,000
| +100% | +$570K | ﹤0.01% | 2952 |
|
|
2020
Q2 | $642K | Buy |
+25,000
| New | +$506K | ﹤0.01% | 3253 |
|
|
2020
Q1 | – | Sell |
-350,000
| Closed | -$12M | – | 4622 |
|
|
2019
Q4 | $12M | Buy |
+350,000
| New | +$4.2M | 0.02% | 1227 |
|
|
2019
Q2 | – | Sell |
-137,500
| Closed | -$1.68M | – | 4551 |
|
|
2019
Q1 | $1.68M | Buy |
+137,500
| New | +$1.76M | ﹤0.01% | 2525 |
|
|
2018
Q4 | – | Sell |
-271,300
| Closed | -$5.89M | – | 4265 |
|
|
2018
Q3 | $5.89M | Buy |
271,300
+21,300
| +9% | +$445K | 0.01% | 1682 |
|
|
2018
Q2 | $4.42M | Buy |
250,000
+50,000
| +25% | +$1.02M | 0.01% | 1891 |
|
|
2018
Q1 | $4.21M | Buy |
+200,000
| New | +$3.9M | 0.01% | 1913 |
|
|
2017
Q4 | – | Sell |
-150,000
| Closed | -$2.37M | – | 4135 |
|
|
2017
Q3 | $2.37M | Buy |
+150,000
| New | +$2.2M | ﹤0.01% | 2082 |
|
|
2016
Q4 | – | Sell |
-150,000
| Closed | -$2.29M | – | 3821 |
|
|
2016
Q3 | $2.29M | Buy |
+150,000
| New | +$6.07M | ﹤0.01% | 1869 |
|
|
2016
Q2 | – | Sell |
-100,000
| Closed | -$2.78M | – | 3667 |
|
|
2016
Q1 | $2.78M | Sell |
100,000
-25,000
| -20% | -$833K | 0.01% | 1607 |
|
|
2015
Q4 | $6.72M | Buy |
+125,000
| New | +$6.31M | 0.01% | 1164 |
|
Other funds holding ITCI
KIM
HNB
Millennium Management's ITCI Position: Q2 2025 in Review
Millennium Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 844,073 shares — an estimated $111M sold.
Millennium Management first reported a position in ITCI in Q1 2014 and held it in 41 quarters. The position peaked at $111M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Millennium Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Millennium Management sold 844,073 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $111M.
- Millennium Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2014 and held it in 41 quarters.
- Millennium Management's Intra-Cellular Therapies Inc. position peaked at $111M in Q1 2025.
- 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.